RESUMEN
Morphological changes in astrocytes occur in a number of brain regions including the hypothalamus and hippocampal regions as a function of hormonal and reproductive state. Because basic fibroblast growth factor has been shown to play an important role in morphological changes in astrocytes, we investigated whether basic fibroblast growth factor immunoreactivity would also be influenced by reproductive state and circulating gonadal steroids. To do this we compared astrocytic basic fibroblast growth factor and glial fibrillary acid protein immunoreactivity in hypothalamic nuclei and the cingulate cortex, area 2 among groups of cycling, late pregnant and lactating rats as well as in ovariectomized and ovariectomized hormone-replaced females. Significant differences in both basic fibroblast growth factor and glial fibrillary acid protein immunoreactivity were observed across groups in the supraoptic nucleus, parvocellular paraventricular nucleus, medial preoptic area of the hypothalamus and cingulate cortex 2. The pattern of change in basic fibroblast growth factor and glial fibrillary acid protein immunoreactivity varied across regions both in direction and magnitude. For example, although in the supraoptic nucleus ovariectomized rats had lower levels of basic fibroblast growth factor-ir than cycling females, this pattern was reversed within cingulate cortex. Overall the results of this study suggest that reproductive and hormonal states are associated with robust changes in basic fibroblast growth factor and glial fibrillary acid protein immunoreactivity in a number of brain areas but that the changes observed vary in magnitude as well as direction from one brain region to another.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/biosíntesis , Proteína Ácida Fibrilar de la Glía/biosíntesis , Hormonas Gonadales/metabolismo , Giro del Cíngulo/fisiología , Hipotálamo/fisiología , Reproducción/fisiología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Femenino , Factor 2 de Crecimiento de Fibroblastos/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/efectos de los fármacos , Hormonas Gonadales/farmacología , Giro del Cíngulo/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Procesamiento de Imagen Asistido por Computador , Inmunohistoquímica , Lactancia/fisiología , Ovariectomía , Embarazo , Ratas , Ratas WistarRESUMEN
Blocking nitric oxide (NO) production, by 3rd ventricle administration of a nitric oxide synthase (NOS) inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME; 250 microg/5 microl, postpartum [pp]) decreased milk ejections in Day 10 pp rats. On Day 4 pp, L-NAME treatment eliminated pup retrieval and at both stages of lactation suppressed maternal aggression. Fewer rats treated with L-NAME on Day 10 pp retrieved 4-day-old pups than controls, although all nursed older litters. Following exposure to a mobile intruder, Fos expression was lower in the medial preoptic area and the bed nucleus of the stria terminalis in L-NAME-treated rats than in controls but was lower in the medial amygdala only following exposure to an anaesthetized intruder. Thus, the elevated levels of NO observed in lactation may contribute to the mechanism(s) that mediate maternal behavior and aggression.
Asunto(s)
Conducta Materna/fisiología , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Área Preóptica/metabolismo , Núcleos Septales/metabolismo , Agresión/efectos de los fármacos , Animales , Animales Recién Nacidos , Recuento de Células/métodos , Inhibidores Enzimáticos/farmacología , Femenino , Inmunohistoquímica/métodos , Inyecciones Intraarticulares/métodos , Lactancia/efectos de los fármacos , Masculino , Proteínas Oncogénicas v-fos/metabolismo , Área Preóptica/efectos de los fármacos , Ratas , Ratas Wistar , Tiempo de Reacción/efectos de los fármacos , Núcleos Septales/efectos de los fármacos , Factores de TiempoRESUMEN
We investigated the contribution of prolactin and oxytocin to the increase in staining for NADPH-d and oxytocin mRNA in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) observed at the end of pregnancy, or following a steroid-priming regimen that mimics the hormonal profile of late pregnant females. Ovariectomized rats received chronic implants of silastic capsules containing oestrogen and progesterone followed by progesterone removal. In experiment 1, oxytocin antagonist (OTA) was administered to rats to investigate whether intranuclear oxytocin release was necessary for NADPH-d staining. In experiments 2a and b, rats received concurrent treatment with bromocryptine (0.5 mg/day) to suppress endogenous prolactin release, and either systemic prolactin (0.5 mg once daily), or prolactin (2 micro g/ micro l), or vehicle infused twice a day into the third ventricle, or chronic oxytocin infusion (24 ng/day) for 3 days following progesterone removal. Brains were then processed for NADPH-d histochemistry. In experiment 3, the interaction of prolactin and oxytocin on oxytocin mRNA within the SON and PVN was examined. NADPH-d staining in the SON and PVN was reduced by the highest dose of the OTA, and by bromocryptine treatment. Central prolactin and oxytocin replacement completely restored NADPH-d staining in bromocryptine-treated rats. Finally, both bromocryptine and the OTA suppressed oxytocin mRNA expression and prolactin replacement restored expression levels to that of controls. Together, these data suggest that the increased capacity to produce nitric oxide in the SON and PVN during late pregnancy is dependent on prolactin stimulating oxytocin gene mRNA and hence intranuclear oxytocin release.
Asunto(s)
Óxido Nítrico Sintasa/metabolismo , Oxitocina/administración & dosificación , Núcleo Hipotalámico Paraventricular/metabolismo , Prolactina/administración & dosificación , Núcleo Supraóptico/metabolismo , Animales , Bromocriptina/farmacología , Implantes de Medicamentos , Interacciones Farmacológicas , Estrógenos/administración & dosificación , Femenino , Histocitoquímica , NADPH Deshidrogenasa/análisis , Ovariectomía , Oxitocina/antagonistas & inhibidores , Oxitocina/genética , Núcleo Hipotalámico Paraventricular/química , Embarazo , Progesterona/administración & dosificación , Prolactina/antagonistas & inhibidores , Prolactina/fisiología , ARN Mensajero/análisis , Ratas , Núcleo Supraóptico/químicaRESUMEN
Three experiments were carried out to investigate the pattern of neuronal activation induced by central oxytocin administration and its modulation by nitric oxide (NO). First, we compared the induction of Fos-like immunoreactivity (lir) in the supraoptic (SON) and paraventricular (PVN) nuclei and medial preoptic area (MPOA) after central oxytocin administration between nonlactating and lactating rats. Next, we investigated whether NO modulated Fos induction following central oxytocin administration using a nitric oxide synthase (NOS) inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME). Finally, to determine whether the effects of NOS inhibition on Fos induction would generalize to stimuli other than oxytocin, we compared Fos-lir in the SON and PVN of lactating and nonlactating rats following L-NAME and urethane administration. In the first two experiments, oxytocin (50 ng in 2 microl) or vehicle was administered into the third ventricle. L-NAME (50 mg/kg) was given by an intraperitoneal (i.p.) injection 30 min before oxytocin administration (experiment 2) or an i.p. injection of urethane (1.4 g/kg) (experiment 3). In all experiments, lactating rats were tested on day 12 or 13 postpartum and nonlactating females at least 11 days after surgery or the start of the experiment. Central oxytocin infusion induced Fos expression in the SON and PVN in lactating and nonlactating rats and in the MPOA and bed nucleus of the stria terminalis in lactating rats. Overall, lactating rats that received L-NAME and oxytocin had a greater number of cells showing Fos-lir in both the SON and PVN. Conversely, L-NAME administration reduced Fos-lir in the SON and PVN in oxytocin-stimulated nonlactating rats. In urethane-treated rats, L-NAME administration did not change Fos-lir in lactating rats but reduced Fos-lir in nonlactating rats. These data suggest that the role of NO in modulating the activity of neurones in discrete nuclei in the hypothalamus varies across reproductive state and with the stimulus presented.
Asunto(s)
Inhibidores Enzimáticos/farmacología , Hipotálamo/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Oxitocina/farmacología , Proteínas Proto-Oncogénicas c-fos/metabolismo , Uretano/farmacología , Animales , Femenino , Hipotálamo/efectos de los fármacos , Inyecciones Intraperitoneales , Inyecciones Intraventriculares , Lactancia/fisiología , Ratas , Ratas WistarRESUMEN
In rats, the length of lactational anovulation is prolonged when litter size is increased or when the dam is food restricted. In both of these situations the energetic demand on the dam is increased, milk delivery to each pup is reduced, and consequently, patterns of pup suckling may be changed. We investigated the contribution of these factors to the maintenance of lactational anovulation by examining the effect of eliminating milk delivery on the length of lactational diestrus in food restricted and ad lib-fed females nursing litters of 8 pups and in females nursing large (14 pups) and small (6 pups) litters. The results of these studies show that preventing milk delivery neither extends the period of lactational infertility in ad lib-fed females nursing eight pups nor eliminates the effects of increasing litter size on this period.
Asunto(s)
Fertilidad/fisiología , Privación de Alimentos/fisiología , Lactancia/fisiología , Tamaño de la Camada/fisiología , Animales , Peso Corporal/fisiología , Diestro/fisiología , Ingestión de Alimentos/fisiología , Metabolismo Energético/fisiología , Femenino , Glándulas Mamarias Animales/fisiología , Ratas , Ratas WistarRESUMEN
Staining for nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d), a histochemical marker for nitric oxide synthase (NOS), is increased in the supraoptic (SON) and paraventricular (PVN) nuclei in late pregnant rats. To determine whether increases in staining were evident at other times during pregnancy and lactation the number of cells that stained for NADPH-d in the SON and PVN in rats on days 4, 12, 16, and 22 of pregnancy and on days 4, 12, and 20 of lactation was compared to that in virgin females. In a second experiment the influence of ovarian hormones on NADPH-d staining was assessed by comparing staining in the SON and PVN among ovariectomized animals exposed to either a steroid hormone replacement schedule that mimics late pregnancy (oestrogen and progesterone with progesterone removal), oestrogen alone, oestrogen and progesterone, or cholesterol alone. In the last experiment of this series staining was compared among ovariectomized animals given either oestrogen or cholesterol priming accompanied by oxytocin (OT) or vehicle infusion into the third ventricle for 7 days. The number of cells showing dense staining for NADPH-d in both the SON and PVN increased on days 12 and 22 of pregnancy and 4 and 12 of lactation compared to that observed in virgins. NADPH-d staining in these areas was also increased by both the steroid treatment that mimicked late pregnancy and chronic central OT infusion in oestrogen-primed animals. These data suggest that NADPH-d staining in the SON and PVN is increased at times when oxytocinergic cells are known to be active and that the hormonal state associated with late pregnancy is sufficient to increase NADPH-d staining.